Big Pharma Immunology Deals Market Research and Analysis - PowerPoint PPT Presentation

About This Presentation
Title:

Big Pharma Immunology Deals Market Research and Analysis

Description:

The report provides a detailed understanding and analysis of how and why companies enter immunology partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors immunology technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not. Delivery of this report will take 1-3 days after purchase. Complete report available @ . – PowerPoint PPT presentation

Number of Views:42

less

Transcript and Presenter's Notes

Title: Big Pharma Immunology Deals Market Research and Analysis


1
Immunology Partnering Terms and Agreements
Published March 2014 No of Pages 1159 Single
User PDF US 2995 Corporate User PDF US
14995
2

Immunology Partnering Terms and Agreements
The Immunology Partnering Terms and Agreements
report provides comprehensive understanding and
unprecedented access to the immunology partnering
deals and agreements entered into by the worlds
leading healthcare companies. The report
provides a detailed understanding and analysis of
how and why companies enter immunology partnering
deals. The majority of deals are discovery or
development stage whereby the licensee obtains a
right or an option right to license the licensors
immunology technology. These deals tend to be
multicomponent, starting with collaborative RD,
and commercialization of outcomes. Understanding
the flexibility of a prospective partners
negotiated deals terms provides critical insight
into the negotiation process in terms of what you
can expect to achieve during the negotiation of
terms. Whilst many smaller companies will be
seeking details of the payments clauses, the
devil is in the detail in terms of how payments
are triggered contract documents provide this
insight where press releases do not. Delivery of
this report will take 1-3 days after
purchase. Complete report available _at_
http//www.lifescienceindustryresearch.com/immunol
ogy-partnering-terms-and-agreements.html.
3

Immunology Partnering Terms and Agreements
This report contains over 1,000 links to online
copies of actual immunology deals and contract
documents as submitted to the Securities Exchange
Commission by companies and their partners.
Contract documents provide the answers to
numerous questions about a prospective partners
flexibility on a wide range of important issues,
many of which will have a significant impact on
each partys ability to derive value from the
deal. The initial chapters of this report provide
an orientation of immunology dealmaking and
business activities. Chapter 1 provides an
introduction to the report. Chapter 2 provides an
overview of the trends in immunology dealmaking
since 2009 covering trends by year, deal type,
stage of development, technology type and
therapeutic indication. In addition the chapter
includes an analysis of financial deal terms by
stage at signing covering headline value, upfront
payment, milestone payments and royalty rates.
Analysis includes median values and distribution
of values for each stage of development. Chapter
3 provides a review of the leading immunology
deals since 2009. Deals are listed by headline
value, signed by bigpharma, most active
bigpharma, and most active of all biopharma
companies. Where the deal has an agreement
contract published at the SEC a link provides
online access to the contract. Delivery of this
report will take 1-3 days after purchase. Order a
copy of this report at _at_ http//www.lifescienceind
ustryresearch.com/purchase?rname3800.
4

Immunology Partnering Terms and Agreements
In conclusion, this report provides everything a
prospective dealmaker needs to know about
partnering in the research, development and
commercialization of immunology technologies and
products. Benefits Immunology Partnering Terms
and Agreements provides the reader with the
following key benefits In-depth understanding of
immunology deal trends since 2009 Access
immunology deal headline, upfront, milestone and
royalty data Research hundreds of actual
contracts between immunology partner
companies Comprehensive access to over 1,000
links to actual immunology deals entered into by
the worlds biopharma companies Indepth review of
immunology deals entered into by the leading
fifty bigpharma companies Benchmark the key deal
terms companies have agreed in previous
deals Identify key terms under which companies
partner immunology opportunities Uncover
companies actively partnering immunology
opportunities Delivery of this report will take
1-3 days after purchase. Inquire Before Buying _at_
http//www.lifescienceindustryresearch.com/inquire
-before-buying?rname3800.
5
About us Life Science Industry
Research brings to you to the latest reports in
market research on Biotechnology, Diagnostics,
Healthcare, Medical Devices and Pharmaceuticals
segments from leading research publishers across
the globe. These reports also cover data and
information on sub-segments and sectors under
these life sciences categories.Contact us
(sales_at_lifescienceindustryresearch.com / 1 888
391 5441) for any of your research requirements
or topics of interest. Our sales research
associates will be happy to help you find
relevant market data.Website
www.lifescienceindustryresearch.com
Browse Latest Industry News, Updates, Trends,
Opportunities, Scenario all over the world _at_
Write a Comment
User Comments (0)
About PowerShow.com